GlaxoSmithKline Consumer Healthcare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GlaxoSmithKline Consumer Healthcare Ltd. on BSE

Search Inside the pdf :

GlaxoSmithKline Consumer Healthcare Ltd.

01 Apr 2020

Corp. Action

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Intimation Of Record Date And Effective Date For Scheme …

BSE India

Please take the context from the pdf file, as it is more than 1000 word context

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

19 Mar 2020

Corp. Note

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Dear Sir / Madam, Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders: Sr.no. Name Folio no. Certificate no. No. of Shares Dist From Dist To 1. Pravin Chandra Chunilal Kothari P01213 107649 50 13250227 13250276 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company. Kindly take the same on record.

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

19 Mar 2020

Corp. Note

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Reg 39 of SEBI (LODR) Regulations, 2015 (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders: Sr.no. Name Folio no. Certificate no. No. of Shares Dist From Dist To 1. Anand Ram Raitani A03726 119137 193009 284334 284335 160 14114885 14442086 28658595 28658645 14114934 14442135 28658644 28658654 2. Gurmehar Singh Majithia G01509 136067 203176 355426 - 355439 1776 12511082 25272645 41754594 12511111 25273724 41755259 3. Mallappa Dodakallappa Hangarki Sharada C Yashoda Hangarki M00546 14492 40510 67528 103070 100 539046 4807839 6735201 12980610 539070 4807850 6735213 12980659 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

13 Mar 2020

Corp. Note

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders: Sr.no. Name Folio no. Certificate no. No. of Shares Dist From Dist To 1. Kantalaxmi S Shah K04208 134813 25 4923657 6852362 4923668 6852374 2. Kantalaxmi Shantilal Shah Shantilal Durlabhdas Shah K00804 65683 121427 18 6671486 12752038 6671494 12752046 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company Kindly take the same on record.

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

13 Mar 2020

Company Update

GlaxoSmithkline Consumer Healthcare Ltd - 500676 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of …

BSE India

Pursuant to Reg 30(7) of SEBI LODR, further to our communication dated Feb 26, 2020, plS see enclosed a copy of the order dated Feb 26, 2020 and clarification dated Feb 28, 2020 alongwith order as per Form CAA 7 issued by the Hon''ble (NCLT), Chandigarh Bench on March 12, 2020 in respect of the scheme of amalgamation amongst GlaxoSmithKline Consumer Healthcare Limited and HUL and their respective shareholders and creditors under Section 230 to 232 of the Companies Act, 2013 ('Scheme'). In this regard, we wish to inform you that in accordance with the terms of the Scheme, a meeting of Board of Director of the Company is scheduled to be held on Wednesday, April 01, 2020, to take on record the sanction of the Scheme by Hon'ble NCLT Mumbai Bench and Chandigarh Bench and to declare the scheme effective. Further, it is to inform you that at this BM will consider the record date for the purpose of issuance of shares of HUL to the shareholders of the Company in accordance with the Scheme.

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

06 Mar 2020

Corp. Note

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Reg 39 of SEBI LODR, we would like to inform you that M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from ShareholderSr.no.Name Folio no. Certificate no. Number of SharesDist FromDist To 1.LCHANDRASEKARL002226698810235921249137425483672052712930326259813864258146267205391293033825981411422 2.MUDUMBI SULOCHANA PADMANABHAN MUDUMBI PADMANABHAN MUDUMBI PADMANABHAN SIDDHARTH M01311261169024274603942746089 42746139 560320 4814241 6740956 12998662 26116901 26116951 42746088 42746138 42746158 3. SUNILA KHANNA S03652 412823 - 412921 263543 263523 263519 5098 44339694 4765100 12808658 1629967 12807670 70036 1629779 44344641 4765106 12808700 1629978 12807707 70047 1629816 4. MALLAPPA DODAKALLAPPA HANGARKI SHARADA C YASHODA HANGARKI M00546 14492 40510 67528 103070 100 539046 4807839 6735201 12980610 539070 4807850 6735213 12980659 We shall issue the duplicate Share Certificate(s)

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

26 Feb 2020

Company Update

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Update On Scheme Of Amalgamation And Arrangement Between Glaxosmithkline …

BSE India

Pursuant to Regulation 30(7) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that Hon''ble National Company Law Tribunal (NCLT), Chandigarh Bench, vide its order dated February 26, 2020, has sanctioned the scheme of amalgamation and arrangement between GlaxoSmithKline Consumer Healthcare Limited ('Transferor Company') and Hindustan Unilever Limited ('Transferee Company') and their respective shareholders and creditors under Section 230 to 232 of the Companies Act, 2013 ('Scheme'). A copy of the order of Hon''ble NCLT is enclosed. The effective date of the merger will be communicated to the stock exchanges upon being finalized in accordance with the procedure stated under the approved Scheme of Amalgamation. Kindly take the same on record.

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

11 Feb 2020

Corp. Note

GlaxoSmithkline Consumer Healthcare Ltd - 500676 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Regulation 39and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from Shareholder: Sr.no. Name Folio no. Certificate no. Number of Shares Dist From Dist To 1. VIDYA K RAMNANI V01101 26719 51924 77778 118636 241694 241695 428289 428290 428291 320 3415445 5123030 7045271 14054760 28109694 28109744 45038879 45038929 45038979 3415469 5123041 7045283 14054809 28109743 28109793 45038928 45038978 45038998 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s).

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

07 Feb 2020

Corp. Note

GLAXOSMITHKLINE CONSUMER HEALTHCARE LTD. - 500676 - Compliances-Reg. 39 (3) - Details of Loss of Certificate …

BSE India

Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Regulations'), we would like to inform you that Registrar and Transfer Agent of Company M/s. KFin Technologies Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholder: Sr.no. Name Folio no. Certificate no. Number of Shares Dist From Dist To 1. B VIMAL KHINVASARA MAHAVEER CHAND B B02429 134069 09 13079562 13079570 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company Kindly take the same on record.

pdf

GlaxoSmithKline Consumer Healthcare Ltd.

06 Feb 2020

Result

GlaxoSmithkline Consumer Healthcare Ltd - 500676 - Unaudited Financial Results For Quarter Ended December 31, 2019

BSE India

Pursuant to Regulation 33 and 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors in its meeting Thursday, February 06, 2020 at 01:30 p.m. at Board Room, One Horizon Centre, DLF Phase - V, Golf Course Road, Gurugram 122002 have, inter alia, considered and taken on record the Unaudited Financial Results for the Quarter ended December 31, 2019. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, we wish to inform you that Mr. Vivek Anand resigned as Chief Financial Officer w.e.f. October 31, 2019 and Mr. Nitin Mathur joined as Head of Finance w.e.f. November 01, 2019. We are enclosing a copy of the Unaudited Financial Results for the Quarter ended December 31, 2019 along with the 'Limited Review' Report, issued by the Auditors for the review done by them, for your records.

pdf

Is GlaxoSmithKline Consumer Healthcare Ltd. worth buying?

60 Votes:

Buy 78.33%

Sell 11.67%

Hold 10.0%